Cellipont Bioservices
Melissa Morales has a diverse work experience starting from 2015. Melissa began their career as a Desk Staffer at the University of Maryland Baltimore County, where they also served as a Front Office Assistant and eventually became a Desk Manager. In these roles, they supervised a team of desk staffers, prepared payroll reports, and conducted weekly staff meetings to ensure efficient procedures.
In 2018, Melissa worked at Northrop Grumman as a Ceramic Material & Process Specialist. Here, they operated manufacturing and research equipment, analyzed process data, and assisted in process improvements related to printed circuit boards.
From 2019 to 2021, Melissa served as an Automation Engineer at Catalent Pharma Solutions. In this position, they contributed to automation engineering projects within the company.
In 2021, Melissa joined Emergent BioSolutions as an Operational Technology Engineer, working until 2022. Their responsibilities likely involved managing and optimizing technology systems.
Currently, Melissa is working as a Senior IT/OT Engineer at Cellipont Bioservices. The details of their responsibilities and job duration at this company are not provided.
Melissa Morales attended the University of Maryland Baltimore County from 2014 to 2018, where they pursued a degree in Chemical Engineering with a focus on Biological Sciences.
This person is not in any offices
Cellipont Bioservices
Cellipont Bioservices is a cell therapy CDMO with more than 15 years’ experience in the development and small-to-large batch manufacturing of cell therapies. Our leaders have played an instrumental role in shaping cell therapy development and manufacturing methods and technologies, and our technically-strong team has been recognized by customers and technology partners for its ability to productively grow challenging cells. Cellipont is driven to help our clients to expand patient access to life-changing medicines through best-in-class development, analytical and manufacturing capabilities. We are a small company with a culture that is extremely responsive and customer-centric. Despite our size, Cellipont Bioservices has very deep technical experience, including 18,000+ tissue samples and more than 900 primary cell cultures. With decades of experience at advanced therapy service companies large and small, our leadership team is guiding Cellipont’s growth with deep knowledge of what it takes succeed in this space. Cellipont Bioservices facilities and quality systems are GMP-compliant and we hold a California Food & Drug Branch manufacturing license. We have extensive experience in multiple product areas, including CAR-T, iNK, dendritic cell, & other novel cell therapy approaches. OUR NAME: By combining “cell” with the latin root for bridge (pont), the name Cellipont Bioservices reflects several dimensions of what we are all about: we bridge our innovator clients with patients; we bridge technical excellence and personal service; and for our team, we bridge personal passion with professional vocation. As we finalize our corporate rebranding, we look forward to launching a new website in the coming weeks to better share our vision with you.